Search

Your search keyword '"van de Velde, Cornelis J.H."' showing total 586 results

Search Constraints

Start Over You searched for: Author "van de Velde, Cornelis J.H." Remove constraint Author: "van de Velde, Cornelis J.H."
586 results on '"van de Velde, Cornelis J.H."'

Search Results

1. Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer

3. Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

6. Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial

8. Microsatellite instability and sex differences in resectable gastric cancer – A pooled analysis of three European cohorts

11. Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery – A Five-year Follow-up of the RAPIDO Trial

12. Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – The RAPIDO trial

13. Supplementary Figure S1 from Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial

15. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer

16. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

17. Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial

19. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation

27. Statin Use After Diagnosis of Colon Cancer and Patient Survival

28. HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

30. Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial

31. Data from Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer

32. Data from Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

33. Supplementary Figure and Table Legends from Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

34. Supplementary Figure 1 from Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

35. Supplemental Methods, supplemental tables 1 to 7, and supplemental figures 1 to 9 from Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer

36. Supplementary Table 1 from Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

37. Relevance of shrinkage versus fragmented response patterns in rectal cancer

38. Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial

39. Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer

45. EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

49. Supplementary Table S1 from Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy

Catalog

Books, media, physical & digital resources